![Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray Analysis | bioRxiv Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray Analysis | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/12/22/2020.12.21.423796/F5.large.jpg)
Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray Analysis | bioRxiv
Full article: MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer
![Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray Analysis | bioRxiv Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray Analysis | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/12/22/2020.12.21.423796/F4.large.jpg)
Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray Analysis | bioRxiv
![Example of a basal-like breast cancer stained with Cytokeratin 5/6,... | Download Scientific Diagram Example of a basal-like breast cancer stained with Cytokeratin 5/6,... | Download Scientific Diagram](https://www.researchgate.net/publication/26696453/figure/fig1/AS:622667673657352@1525466950785/Example-of-a-basal-like-breast-cancer-stained-with-Cytokeratin-5-6-Cytokerratin-14.png)
Example of a basal-like breast cancer stained with Cytokeratin 5/6,... | Download Scientific Diagram
![alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies | BMC Clinical Pathology | Full Text alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies | BMC Clinical Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1472-6890-14-28/MediaObjects/12907_2013_Article_171_Fig2_HTML.jpg)
alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies | BMC Clinical Pathology | Full Text
![CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer | Oncogene CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer | Oncogene](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41388-021-01975-3/MediaObjects/41388_2021_1975_Fig1_HTML.png)
CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer | Oncogene
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Ch
![PDF) Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists | Sunil Badve - Academia.edu PDF) Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists | Sunil Badve - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43907576/mini_magick20190215-25358-1k7chgr.png?1550245246)
PDF) Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists | Sunil Badve - Academia.edu
![Frontiers | 'Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics' Frontiers | 'Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics'](https://www.frontiersin.org/files/Articles/783494/fmolb-09-783494-HTML-r1/image_m/fmolb-09-783494-g002.jpg)
Frontiers | 'Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics'
![alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies | BMC Clinical Pathology | Full Text alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies | BMC Clinical Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1472-6890-14-28/MediaObjects/12907_2013_Article_171_Fig1_HTML.jpg)
alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies | BMC Clinical Pathology | Full Text
The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set | PLOS ONE
![How different are luminal A and basal breast cancers? - Bertucci - 2009 - International Journal of Cancer - Wiley Online Library How different are luminal A and basal breast cancers? - Bertucci - 2009 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/86de9512-005b-477a-83e8-20050b64dfdb/mfig002.jpg)
How different are luminal A and basal breast cancers? - Bertucci - 2009 - International Journal of Cancer - Wiley Online Library
![PDF] Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. | Semantic Scholar PDF] Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/033bbabb417eeef47ec5346cab08e8b3afa8c698/2-Table1-1.png)